Clinical trial
Multimodal Biomarkers for Diagnosis and Prognosis in Cerebral Amyloid Angiopathy
NCT03969732 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Biomarkers for Diagnosis and Prognosis in Cerebral Amyloid Angiopathy
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 27, 2018
- Completion date
- July 31, 2022
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.